Back
ChromaDex 10K Form
Buy
55
CDXC
ChromaDex
Last Price:
$5.46
Seasonality Move:
16.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | CDXC/ChromaDex Quarterly |
| 2023-08-09 | 10Q | CDXC/ChromaDex Quarterly |
| 2023-05-10 | 10Q | CDXC/ChromaDex Quarterly |
| 2022-11-02 | 10Q | CDXC/ChromaDex Quarterly |
| 2022-08-10 | 10Q | CDXC/ChromaDex Quarterly |
| 2022-05-12 | 10Q | CDXC/ChromaDex Quarterly |
Receive CDXC News And Ratings
See the #1 stock for the next 7 days that we like better than CDXC
CDXC Financial Statistics
Sales & Book Value
| Annual Sales: | $83.6M |
|---|---|
| Cash Flow: | $3.5M |
| Price / Cash Flow: | 101.91 |
| Annual Sales: | $0.45 |
| Price / Book: | 12.11 |
Profitability
| EPS (TTM): | 0.00980 |
|---|---|
| Net Income (TTM): | $1.5M |
| Gross Margin: | $50.8M |
| Return on Equity: | 4.96% |
| Return on Assets: | 2.72% |
ChromaDex Earnings Forecast
Key ChromaDex Financial Ratios
-
The Gross Profit Margin over the past 16 years for CDXC is 60.76%.
-
The Selling, General & Administrative Expenses for CDXC have been equal to 61.53% of Gross Profit Margin.
-
The Research & Development expenses have been 5.93% of Revenue.
-
The Interest Expense is -0.22% of Operating Income.
-
The Net Earning history of CDXC is -5.91% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 7 years.
ChromaDex Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CDXC |
| CUSIP: | 171077 |
| Website: | chromadex.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.95 |
| Quick Ratio: | 2.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 32.06 |